A common polymorphism in the annexin V Kozak sequence (−1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients
Open Access
- 15 September 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (6) , 2081-2086
- https://doi.org/10.1182/blood.v100.6.2081
Abstract
Annexin V has phospholipid-binding capacity and plays a potent antithrombotic role. Recently, a C to T transition has been described in the Kozak region of this gene, affecting the nucleotide preceding the initiation ATG codon. We have developed a simple method to detect this genetic change, showing by analysis of 580 Mediterranean white subjects that the −1C to T transition (−1C>T) is a common polymorphism (allele frequency, 0.121). This polymorphism is in linkage disequilibrium with a new C>G polymorphism located 27 bp downstream in intron 2. We show that −1C/C carriers presented significantly lower plasma levels of annexin V than −1C/T subjects (0.45 ± 0.20 ng/mL versus 0.73 ± 0.28 ng/mL, respectively;P = .02). In vitro transcription/translation experiments support that the −1T allele increases translation efficiency. The clinical relevance of the −1C>T change was investigated in consecutive patients with nontraumatic spontaneous intracranial hemorrhage (n = 225), deep venous thrombosis (n = 151), and coronary heart disease (n = 101). Finally, we also studied 166 survivors of an acute myocardial infarction occurring at age of 45 or less. This polymorphism seems to have a minor effect in bleeding disorders, but to play a protective role against early myocardial infarction, reducing by 2-fold the risk of developing the disease (P = .006; odds ratio, 0.51; 95% confidence interval, 0.30-0.85).Keywords
This publication has 27 references indexed in Scilit:
- Elevated Levels of Shed Membrane Microparticles With Procoagulant Potential in the Peripheral Circulating Blood of Patients With Acute Coronary SyndromesCirculation, 2000
- Competition of Annexin V and Anticardiolipin Antibodies for Binding to Phosphatidylserine Containing MembranesBiochemistry, 2000
- Tissue factor de-encryptionBlood Coagulation & Fibrinolysis, 1999
- Shed Membrane Microparticles With Procoagulant Potential in Human Atherosclerotic PlaquesCirculation, 1999
- Preparation and Characterization of a Disulfide-Linked Bioconjugate of Annexin V with the B-Chain of Urokinase: An Improved Fibrinolytic Agent Targeted to Phospholipid-Containing ThrombiBiochemistry, 1996
- Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Organization of the Human Annexin V (ANX5) GeneGenomics, 1994
- Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cellsBiochemical Journal, 1992
- Expression of annexins as a function of cellular growth state.The Journal of cell biology, 1990
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesCell, 1986